Immunosurveillance is generally mediated by type 1 CD4+ T-helper (TH1) cells and CD8+ cytotoxic T lymphocytes (CTLs), which specifically recognize antigenic epitopes emerging during malignant transformation and tumor progression8–13. This evidence concerns the gene CD8A and neoplasm.